756
Views
12
CrossRef citations to date
0
Altmetric
Review

Hemostatic defects in massive transfusion: an update and treatment recommendations

Pages 219-239 | Received 10 Mar 2020, Accepted 30 Nov 2020, Published online: 06 Jan 2021

References

  • Sihler KC, Napolitano LM. Massive Transfusion. CHEST. 2009;136(6):1654–1667.
  • Savage SA, Sumislawski JJ, Zarzaur BL, et al. The new metric to define large-volume hemorrhage: results of a prospective study of the critical administration threshold. J Trauma Acute Care Surg. 2015 Feb;;78(2):224–229. discussion 229-30..
  • Meyer DE, Cotton BA, Fox EE, et al. A comparison of resuscitation intensity and critical administration threshold in predicting early mortality among bleeding patients: A multicenter validation in 680 major transfusion patients. J Trauma Acute Care Surg. 2018;85(4):691.
  • Hsu Y, Haas T, Cushing M. Massive transfusion protocols: current best practice. International Journal of Clinical Transfusion Medicine.. 2016;4:15–27. https://doi.org/10.2147/IJCTM.S61916
  • Spahn DR, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma. Crit Care. 2019 March 27;23(1):98. fifth edition.
  • Hunt BJ, Allard S, Keeling D, et al. on behalf of the British Committee for Standards in Haematology. 2015;170:788–803. A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 170:788–803. https://doi.org/10.1111/bjh.13580.
  • ACS TQIP Massive Transfusion in Trauma Guidelines. https://www.facs.org/-/media/files/quality-programs/trauma/tqip/transfusion_guildelines.ashx?la=en. Accessed 2020 Jan 9.
  • Callum JL, Yeh CH, Petrosoniak A, et al. A regional massive hemorrhage protocol developed through a modified Delphi technique. CMAJ Open. 2019 Sep 3. 7: 3; E546–E561 Print 2019Jul-Sep PMID: 31484650
  • Patient Blood Management Guidelines for Critical Bleeding and Massive Transfusion. Massive transfusion protocol template and suggested criteria for activation of MTP. https://www.blood.gov.au/pubs/pbm/module1/transfusion.html. Accessed 2020 Jan 9.
  • Etchill E, Sperry J, Zuckerbraun B, et al. The confusion continues: results from an American Association for the Surgery of Trauma survey on massive transfusion practices among United States trauma centers. Transfusion. 2016 Oct;56(10):2478–2486. .
  • Patel EU, Ness PM, Marshall CE, et al. Blood Product Utilization Among Trauma and Nontrauma Massive Transfusion Protocols at an Urban Academic Medical Center. Anesth Analg. 2017 Sep;125(3):967–974. .
  • Thomasson RR, Yazer MH, Gorham JD, et al. Investigators, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. International assessment of massive transfusion protocol contents and indications for activation. Transfusion. 2019 May;59(5):1637–1643. 2019 Feb 5. Epub:
  • Hoffman M, Monroe DM. 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001 Jun;85(6):958–965.
  • Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007 Feb;21(1):1–11.
  • Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009 May;108(5):1433–1446. .
  • Stettler GR, Moore EE, Moore HB, et al. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits. J Trauma Acute Care Surg. 2019 Sept;87(3):582–589. .
  • Tanaka KA, Henderson RA, Strauss ER. Evolution of viscoelastic coagulation testing. Expert Rev Hematol. 2020 May;13(7):697–707. .
  • Hunt H, Stanworth S, Curry N et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev. 2015 Feb 16;2:CD010438. Doi:10.1002/14651858.CD010438.pub2.. PMID: 25686465; PMCID: PMC7083579.
  • Levy JH, Dutton RP, Hemphill JC, et al. Hemostasis Summit Participants. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010 Feb 1;110(2):354–364. 3rd.
  • Hardy JF, De Moerloose P, Samama M. Groupe d’intérêt en Hémostase Périopératoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth. 2004;51(4):293.
  • Polderman KH. Hypothermia and coagulation. Crit Care. 2012 2020 Jan 9;16:A20. Accessed
  • De Robertis E, Kozek-Langenecker SA, Tufano R, et al. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding. Minerva Anestesiol. 2015 Jan;81(1):65–75.
  • Martini WZ. Coagulation complications following trauma. Mil Med Res. 2016 Nov 22;3:35. doi:10.1186/s40779-016-0105-2.
  • Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma. 2009 Jul;67(1):202–208. . discussion 208–9.
  • Ditzel R, Michael J, Anderson J, et al. A review of transfusion- and trauma-induced hypocalcemia: is it time to change the lethal triad to the lethal diamond? J Trauma Acute Care Surg. 2020 March; 88(3):434–439.
  • Moore HB, Tessmer MT, Moore EE, et al. Forgot calcium? Admission ionized calcium in two civilian randomized controlled trials of pre-hospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg. 2020 Feb 10. doi: 10.1097/TA.0000000000002614. [ Epub ahead of print].
  • Giancarelli A, Birrer KL, Alban RF, et al. Hypocalcemia in trauma patients receiving massive transfusion. J Surg Res. 2016 May 1;;202(1):182–187. Epub 2015 Dec 30.
  • MacKay EJ, Stubna MD, Holena DN, et al. Abnormal Calcium Levels During Trauma Resuscitation Are Associated with Increased Mortality, Increased Blood Product Use, and Greater Hospital Resource Consumption: A Pilot Investigation. Anesth Analg. 2017 Sep;125(3):895–901.
  • Kyle T, Greaves I, Beynon A, et al. Ionised calcium levels in major trauma patients who received blood en route to a military medical treatment facility. Emerg Med J. 2017;1–4. DOI:10.1136/emermed-2017-206717.
  • Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism. Crit Care. 2017;21(1):25.
  • Henriksen HH, McGarrity S, SigurDardottir RS. et al. Metabolic systems analysis of shock-induced endotheliopathy (SHINE) in trauma: A new research paradigm. Ann Surg. Jun 2019. Epub ahead of print. Doi:10.1097/sla.0000000000003307
  • Kashuk JL, Moore EE, Sawyer M, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010;251:604–614.
  • Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma. 2011;71:407.
  • Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263:1051–1059.
  • Einersen PM, Moore EE, Chapman MP, et al. Rapid thrombelastography thresholds for goal-directed resuscitation of patients at risk for massive transfusion. J Trauma Acute Care Surg. 2017;82:114–119.
  • Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011 Nov;71(5 Suppl 1):S427–34.
  • Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748–754.
  • Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54:1127–1130.
  • MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39e44.
  • Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma. 2008;64(6): 1459–1463. discussion 63–5.
  • Maegele M, Lefering R, Yucel N, et al. AG Polytrauma of the German Trauma Society (DGU)Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38(3):298–304.
  • Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma. 2011;71(5 Suppl 1):S427–S434.
  • Moore HB, Moore EE, Chapman MP, et al. Viscoelastic tissue plasminogen activator challenge predicts massive transfusion in 15 minutes. J Am Coll Surg. 2017;225(1):138–147.
  • Wohlauer MV, Moore EE, Thomas S, et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg. 2012;214(5):739–746.
  • Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth. 2010 Aug;105(2):116–121.
  • Christie SA, Kornblith LZ, Howard BM, et al. Characterization of distinct coagulopathic phenotypes in injury: pathway-specific drivers and implications for individualized treatment. J Trauma Acute Care Surg. 2017 Jun;82(6):1055–1062.
  • Sumislawski JJ, Christie SA, Kornblith LZ, et al. Discrepancies between conventional and viscoelastic assays in identifying trauma-induced coagulopathy. Am J Surg. 2019 Jun;217(6):1037–1041.
  • Duque P, Mora L, Levy JH, et al. Response to Trauma-Induced Coagulopathy: A Comprehensive Review. Anesth Analg. 2020 Mar;130(3):654–664. . PMID: 31633501.
  • Moore HB, Moore EE, Liras IN, et al. Targeting resuscitation to normalization of coagulating status: hyper and hypocoagulability after severe injury are both associated with increased mortality. Am J Surg. 2017;214:1041–1045.
  • Moore HB, Moore EE, Gonzalez E, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014 Dec;77(6):811–817. discussion 817.
  • Moore HB, Moore EE, Liras IN, et al. Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients. J Am Coll Surg. 2016 Apr;222(4):347–355.
  • Cannon JW. Hemorrhagic Shock. New Engl J Med. 2018;378:370–379.
  • Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307–310.
  • Joint Trauma System Clinical Practice Guideline (JTS CPG) for Damage Control Resuscitation 2019. https://jts.amedd.army.mil/assets/docs/cpgs/JTS_Clinical_Practice_Guidelines_(CPGs)/Damage_Control_Resuscitation_12_Jul_2019_ID18.pdf. Accessed 2020 Jan 9.
  • Cannon JW, Khan MA, Raja AS, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017;82(3):605–617.
  • NICE. Major trauma: assessment and initial management. Available at: https://www.nice.org.uk/guidance/ng39/chapter/Recommendations#management-of-haemorrhage-in-prehospital-and-hospital-settings. Accessed 2020 Jan 9.
  • Holcomb JB, Del Junco DJ, Fox EE, et al. PROMMTT Study Group. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–136.
  • Holcomb JB, Tilley BC, Baraniuk S, et al. PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–482.
  • Cole E, Weaver A, Gall L, et al. A decade of damage control resuscitation: new transfusion practice, new survivors, new directions. Ann Surg. 2019 Oct 22 Online ahead of print. Doi: 10.1097/SLA.0000000000003657.
  • Hartmann J, Walsh M, Grisoli A, et al. Diagnosis and Treatment of Trauma-Induced Coagulopathy by Viscoelastography. Semin Thromb Hemost. 2020, Mar;462:134–146 Epub 2020 Mar 11 PMID: 32160640
  • Dzik W, Blajchman MA, Fergusson D, et al. Clinical review: canadian national advisory committee on blood and blood products – massive transfusion consensus conference 2011: report of the panel. Crit Care. 2011 [2020 Jan 9];15:242. Accessed https://ccforum.biomedcentral.com/articles/10.1186/cc10498
  • Caspers M, Maegele M, Fröhlich M. Current strategies for hemostatic control in acute trauma hemorrhage and trauma-induced coagulopathy. Expert Rev Hematol. 2018 Dec;11(12):987–995. .
  • Baksaas-Aasen K, Gall L, Eaglestone S, et al. iTACTIC - implementing treatment algorithms for the correction of trauma-induced coagulopathy: study protocol for a multicentre, randomised controlled trial. Trials. 2017;18:486. https://doi.org/10.1186/s13063-017-2224-9
  • TACTIC Consortium and iTACTIC Protocol Summary: https://www.c4ts.qmul.ac.uk/intrn-projects/itactic. Accessed.
  • Baksaas-Aasen K, Gall LS, Stensballe J, et al. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med. 2020 Oct 13:1–11. Online ahead of print. DOI: 10.1007/s00134-020-06266-1.
  • Oyeniyi BT, Fox EE, Scerbo M, et al. Trends in 1029 trauma deaths at a level 1 trauma center: impact of a bleeding control bundle of care. Injury. 2017 Jan;48(1):5–12.
  • Schlimp CJ, Voelcket W, Inaba K, et al. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care. 2013;17(4):R137.
  • Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342–1351.
  • McQuilten ZK, Wood EM, Bailey M, et al. Fibrinogen is an independent predictor of mortality in major trauma patients: A five-year statewide cohort study. Injury. 2017;48(5):1074–1081.
  • Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2014 May;54(5):1389–1405. quiz 1388.
  • McNamara H, Kenyon C, Smith R, et al. Four years’ experience of a ROTEM®-guided algorithm for treatment of coagulopathy in obstetric haemorrhage. Anaesthesia. 2019;74(8):984–991.
  • Chow JH, Richards JE, Morrison JJ, et al. Viscoelastic Signals for Optimal Resuscitation in Trauma: kaolin Thrombelastography Cutoffs for Diagnosing Hypofibrinogenemia (VISOR Study). Anesth Analg. 2019 Dec;129(6):1482–1491.
  • Peng HT, Nascimento B, Tien H, et al. A comparative study of viscoelastic hemostatic assays and conventional coagulation tests in trauma patients receiving fibrinogen concentrate. Clin Chim Acta. 2019 Aug;495:253–262. Epub [2019 Apr 17].
  • Grottke O, Mallaiah S, Karkouti K, et al. Fibrinogen Supplementation and Its Indications. Semin Thromb Hemost. [2019 Oct 1]. Epub ahead of print. DOI:10.1055/s-0039-1696946.
  • Green L, Bolton‐Maggs P, Beattie C, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. Br J Haematol. 2018;181:54–67.
  • Doyle S, O’Brien P, Murphy K, et al. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis. 2003;14:283–287.
  • Collins PW, Solomon C, Sutor K, et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth. 2014;113(4):585–595.
  • Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowledge. Transfus Med Rev. 2009;23(3):177–188.
  • Seebold JA, Campbell D, Wake E, et al. Targeted fibrinogen concentrate use in severe traumatic haemorrhage. Crit Care Resusc. 2019 Sep;21(3):171–178.
  • Ranucci M, DeDedda U, Baryshnikova E. Trials and tribulations of viscoelastic-based determinations of fibrinogen concentration. Anesth Analg. 2020 Mar;130(3):644–653.
  • Lunde J, Stensballe J, Wikkelsø A, et al. Fibrinogen concentrate for bleeding–a systematic review. Acta Anaesthesiol Scand. 2014 Oct;58(9):1061–1074.
  • Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, et al. Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2016;30(5):1196–1204.
  • Manco‐Johnson MJ, Dimichele D, Castaman G, et al. Fibrinogen Concentrate Study Group. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost. 2009;7:2064–2069.
  • Innerhofer P, Fries D, Mittermayr M, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258–e271.
  • Nascimento B, Callum J, Tien H, et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth. 2016;117:775–782.
  • Curry N, Foley C, Wong H, et al. Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. Crit Care. 2018;22:164.
  • Maegele M, Zinser M, Schlimp C, et al. Injectable hemostatic adjuncts in trauma: fibrinogen and the FIinTIC study. J Trauma Acute Care Surg. 2015;78:S76–S82.
  • Nascimento B, Goodnough LT, Levy JH. Cryoprecipitate therapy. Br J Anaesth. 2014 Dec;113(6):922–934. Epub 2014 Jun 27.
  • Stabler SN, Li SS, Karpov A, et al. Use of Fibrinogen Concentrate for Trauma-Related Bleeding. J Trauma Acute Care Surg. 2020 August 28. Epub ahead of print. DOI:10.1097/TA.0000000000002920.
  • Curry N, Rourke C, Davenport R, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015 Jul;115(1):76–83. Epub 2015 May 19..
  • Marsden M, Benger J, Brohi K, et al. on behalf of the CRYOSTAT-2 Investigators. Coagulopathy, cryoprecipitate and CRYOSTAT-2: realising the potential of a nationwide trauma system for a national clinical trial. Br J Anaesth. 2019 February;122(2):164–169.
  • Winearls . J, Wullschleger M, Wake E, et al. Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial. Trials. 2017 May 26;18(1):241.
  • ClinicalTrials.gov, ID: NCT02745041. Registered 2016 May 4
  • Winearls J, Wullschleger M, Wake E, et al. Fibrinogen early in severe trauma study (FEISTY): study protocol for a randomized controlled trial. Trials. 2017;18:241.
  • Li JY, Gong J, Zhu F, et al. Fibrinogen concentrate in cardiovascular surgery: A meta-analysis of randomized controlled trials. Anesth Analg. 2018 Sep;127(3):612–621.
  • Callum J, Farkouh ME, Scales DC, et al. FIBRES Research Group. Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: the FIBRES Randomized Clinical Trial. JAMA. 2019 Oct 21:1–11. Epub ahead of print. Doi:10.1001/jama.2019.17312.
  • Hess AS, Hess JR, Coursin DB. Should fibrinogen concentrate replace cryoprecipitate in cardiac surgery. Editorial JAMA. 2019;32220:1958–1960.
  • Jehan F, Aziz H, O’Keeffe T, et al. The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis. J Trauma Acute Care Surg. 2018 Jul;85(1):18–24. .
  • Zeeshan M, Hamidi M, Kulvatunyou N, et al. 3-Factor Versus 4-Factor PCC in Coagulopathy of Trauma: four is Better Than Three. Shock. 2019 Jul;52(1):23–28.
  • Zeeshan M, Hamidi M, Feinstein AJ, et al. Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis. J Trauma Acute Care Surg. 2019 Aug;87(2):274–281. .
  • Peralta MR, Chowdary P. The use of new procoagulants in blunt and penetrating trauma. Curr Opin Anaesthesiol. 2019 Apr;32(2):200–205.
  • CRASH-2 trial collaborators, Shakur H, Roberts I, et al.; CRASH-2 collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23–32.
  • Napolitano LM, Cohen MJ, Cotton BA, et al. Tranexamic acid in trauma how should we use it? J Trauma Acute Care Surg. 2013 Jun;74(6):1575–1586. PMID:23694890.
  • Reade MC, Pitt V, Gruen RL. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013;40:160–161.
  • Ramirez RJ, Spinella PC, Bochicchio GV. Tranexamic Acid Update in Trauma. Crit Care Clin. 2017 Jan;33(1):85–99. .
  • Valle EJ, Allen CJ, Van Haren RM. Do all trauma patients benefit from tranexamic acid. J Trauma Acute Care Surg. 2014;76:1373–1378.
  • Harvin JA, Peirce CA, Mims MM, et al. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg. 2015;78:905–911.
  • Cole E, Davenport R, Willett K, et al. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: A prospective cohort study. Ann Surg. 2015 Feb;261(2):390–394.
  • Khan M, Jehan F, Bulger EM, et al. PROPPR Study Group. Severely injured trauma patients with admission hyperfibrinolysis: is there a role of tranexamic acid? Findings from the PROPPR trial. J Trauma Acute Care Surg. 2018 Nov;85(5):851–857.
  • Meizoso JP, Dudaryk R, Mulder MB, et al. Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid. J Trauma Acute Care Surg. 2018 Mar;84(3):426–432.
  • Moore HB, Moore EE, Chapman MP, et al. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography? J Am Coll Surg. 2019 Jul;229(1):92–101. Epub 2019 Mar 29..
  • Stettler GR, Moore EE, Moore HB, et al. Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays. J Trauma Acute Care Surg. 2019 Apr;86(4):679–685.
  • Moore HB, Moore EE, Neal MD, et al. Fibrinolysis Shutdown in Trauma: historical Review and Clinical Implications. Anesth Analg. 2019 Sep;129(3):762–773. .
  • Jawa RS, Singer A, McCormack J, et al. Tranexamic acid use in United States Trauma Centers: A national survey. Am Surg. 2016 May;82(5):439–447.
  • Napolitano LM. Prehospital tranexamic acid: what is the current evidence? Trauma Surg Acute Care Open. 2017 Jan 13;2(1):e000056. .
  • Fischer PE, Bulger EM, Perina DG, et al. Guidance Document for the Prehospital Use of Tranexamic Acid in Injured Patients.. Prehosp Emerg Care. 2016 Sep-Oct;;20(5):557–559. Epub [2016 Mar 17].
  • Ausset S, Glassberg E, Nadler R, et al. Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting:a critical appraisal of the medical literature and available alternatives. J Trauma Acute Care Surg. 2015;78((Suppl 1)):S70–5.
  • Brown JB, Neal MD, Guyette FX, et al. Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) trial: addressing the knowledge gaps. Prehosp Emerg Care. 2015;19:79–86. https://crisma.upmc.com/apps/staamp/ Accessed 2020 Jan 9
  • https://www.patchtrauma.org/.https://clinicaltrials.gov/ct2/show/NCT02187120?term=NCT02187120&rank=1 Accessed 2020 Jan 9.
  • Guyette FX, Brown JB, Zenati M, et al. STAAMP Study Group. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: A double-blind, placebo-controlled, randomized clinical trial. JAMA Surg. 2020 Oct 5. e204350. Doi:10.1001/jamasurg.2020.4350.. Online ahead of print
  • Bocci MG, Nardi G, Veronesi G, et al. Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres. Injury. 2019 Oct;50(10):1671–1677. . PMID:31690405
  • Nardi G, Agostini V, Rondinelli B, et al. Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care. 2015 Mar 12;19:83.
  • Schöchl H, Maegele M, Solomon C, et al. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012;20(15). DOI:10.1186/1757-7241-20-15
  • Schöchl H, Voelckel W, Grassetto A, et al. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg. 2013 Jun;74(6):1587–1598; Review. PubMed PMID: 23694891. .
  • Holcomb JB, Jenkins D. Get ready: whole blood is back and it’s good for patients. Transfusion. 2018;58:1821–1823.
  • Black JA, Pierce VS, Kerby JD, et al. The evolution of blood transfusion in the trauma patient: whole blood has come full circle. Semin Thromb Hemost. 2019 Dec 30. doi:10.1055/s-0039-3402426.. Epub ahead of print PMID: 31887756
  • Nessen SC, Eastridge BJ, Cronk D, et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion. 2013;53(suppl 1):107S–13S.
  • Perkins JG, Cap AP, Spinella PC, et al. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion. 2011;51:242–252.
  • Spinella PC, Perkins JG, Grathwohl KW, et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma. 2009;66(4 suppl):S69–76.
  • Williams J, Merutka N, Meyer D. et al. Safety profile and impact of low-titer group O whole blood for emergency use in trauma. J Trauma and Acute Care Surg. 2020;88(1):87–93.
  • Zhu CS, Pokorny DM, Eastridge BJ, et al. Give the trauma patient what they bleed, when and where they need it: establishing a comprehensive regional system of resuscitation based on patient need utilizing cold-stored, low-titer O+ whole blood. Transfusion. 2019;59(S2):1429–1438.
  • Cotton BA, Podbielski J, Camp E, et al. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013;258:527–532.
  • Crowe E, DeSantis S, Bonnette A, et al. Whole blood transfusion versus component therapy in trauma resuscitation: A systematic review and meta-analysis. J Am Coll Emerg Physicians Open. 2020 Aug;1(4):633–641.
  • Jansen JO, Wang H, Holcomb JB, et al. Elicitation of prior probability distributions for a proposed Bayesian randomized clinical trial of whole blood for trauma resuscitation. Transfusion. 2020 Jan 22. DOI:10.1111/trf.15675.. [ Epub ahead of print].
  • Bahr TM, DuPont TL, Morris DS, et al. First report of using low-titer cold-stored type O whole blood in massive postpartum hemorrhage. Transfusion. 2019 October;59(10):3089–3092.
  • Yazer MH, Cap AP, Spinella PC. Raising the standards on whole blood. J Trauma Acute Care Surg. 2018;84(6S, Suppl 1):S14–S17.
  • Strandenes G, Berséus O, Cap AP, et al. Low titer group O whole blood in emergency situations. Shock. 2014;41(Suppl. 01):70–75.
  • Seheult JN, Triulzi DJ, Alarcon LH, et al. Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre. Transfus Med. 2017;27(1):30–35.
  • Spinella PC, Pidcoke HF, Strandenes G, et al. Whole blood for hemostatic resuscitation of major bleeding. Transfusion. 2016;56(Suppl. 02):S190–S202.
  • Yazer MH, Spinella PC. The use of low-titer group O whole blood for the resuscitation of civilian trauma patients in 2018. Transfusion. 2018;58(11):2744–2746.
  • Yazer MH, Spinella PC, Doyle L, et al. for the Biomedical Excellence for Safer Transfusion Collaborative; Appendix. Members of the Biomedical Excellence for Safer Transfusion Collaborative. Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO Typings. Anesthesiology. [2019 Nov 25]. Epub ahead of print. DOI:10.1097/ALN.0000000000003069.
  • Sperry JL, Guyette FX, Brown JB, et al. PAMPer Study Group. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315–326.
  • Moore HB, Moore EE, Chapman MP, et al. Plasma-First Resuscitation to Treat Haemorrhagic Shock During Emergency Ground Transportation in an Urban Area: A Randomised Trial. Lancet. 2018 Jul 28;392(10144):283–291.
  • Pusateri AE, Moore EE, Moore HB, et al. Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials. JAMA Surg. 2019 Dec 18. e195085. DOI:10.1001/jamasurg.2019.5085. Epub ahead of print
  • Chapman MP, Moore EE, Moore HB, et al. Plasma-first resuscitation to treat haemorrhagic shock in urban areas – author’s reply. Lancet. 2020 Feb;395(10224):562–563.
  • Moore HB, Moore EE, Chapman MP, et al. Viscoelastic tissue plasminogen activator challenge predicts massive transfusion in 15 minutes. J Am Coll Surg. 2017;225:138–147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.